AboutContactTerms & Privacy
© 2025 Coverager
All Rights Reserved

Metsera

Developer of oral and injectable therapies for obesity and metabolic diseases.

Headquarters
New York, New York, United States
Founded
2022
Operating Status
Active
Ownership Type
Links
Number of funding rounds 3
Number of investors 17
Total funding amount $505M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.